• 2009
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003
• 2002

FOXM1: The Achilles' heel of cancer? - p242

Senthil K. Radhakrishnan & Andrei L. Gartel

doi:10.1038/nrc2223-c1

• Full Text
• PDF (110 KB)

Targeting FOXM1 - p242

Stephen S. Myatt & Eric W.-F. Lam

doi:10.1038/nrc2223-c2

• Full Text
• PDF (101 KB)

BCR–ABL and CDKN2A: a dropped connection - p563

Richard T. Williams & Charles J. Sherr

doi:10.1038/nrc2368-c1

• Full Text
• PDF (107 KB)

Cell-cycle deregulation in progressive CML - p563

Michael Savona & Moshe Talpaz

doi:10.1038/nrc2368-c2

• Full Text
• PDF (116 KB)

Opinions regarding cord blood use need an update - p823

J. J. Nietfeld

doi:10.1038/nrc2418-c1

• Full Text
• PDF (142 KB)

Cord blood stem cells: worth the investment - p823

David T. Harris

doi:10.1038/nrc2418-c2

• Full Text
• PDF (104 KB)

Banking on cord blood stem cells - p823

Michael J. Sullivan

doi:10.1038/nrc2418-c3

• Full Text
• PDF (142 KB)

Towards a hybrid model for the cryopreservation of umbilical cord blood stem cells - p823

Zafiris Polymenidis & George P. Patrinos

doi:10.1038/nrc2418-c4

• Full Text
• PDF (101 KB)

On clonogenic tumour cells and metastasis-forming cells - p990

Maurice Tubiana & Serge Koscielny

doi:10.1038/nrc2419-c1

• Full Text
• PDF (0KB)

Clonogens and cancer stem cells - p990

Michael Baumann, Mechthild Krause & Richard Hill

doi:10.1038/nrc2419-c2

• Full Text
• PDF (0KB)

Peripheral neurotoxicity of platinum-based chemotherapy

Guido Cavaletti

doi:10.1038/nrc2167-c1

• Full Text
• PDF (115 KB)

The author's response

Lloyd Kelland

doi:10.1038/nrc2167-c2

• Full Text
• PDF (76 KB)